Aspergillus oryzae

DB10448ApprovedAllergenics

Aspergillus oryzae is an extract from Aspergillus oryzae used in allergy testing.

First approval
Canada, 1995 · United States, 1965
Also known as
Aspergillus flavus var. oryzae · Aspergillus flavus var. oryzae whole · Eurotium oryzae

Resolves to

Compound
UNIIQ6Z8UK5R3G
Clinical / RWD
RxNorm1329940

What you can answer from here — as of June 12, 2020

1Structured indicationCondition, population, route and combination as fields, not prose
Sign in
16Marketed productsAcross 2 countries and 4 labellers
Sign in

Which other approved drugs treat the same conditions as Aspergillus oryzae, and which companies have late-stage candidates in those indications?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In